• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home Investing

New Evidence Underscores the Value of Tobacco Harm Reduction

by
July 16, 2025
in Investing
0
New Evidence Underscores the Value of Tobacco Harm Reduction
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Jeffrey A. Singer

Chapter 10 of Your Body, Your Health Care covers tobacco harm reduction by exploring various nicotine delivery systems that are safer than combustible tobacco, which causes the harmful chemicals linked to cancer, lung disease, and cardiovascular disease.

A study published this week in the Annals of Internal Medicine by researchers at the University of New South Wales found that nicotine e‑cigarettes are more effective than nicotine lozenges or gum in helping people quit smoking. This study reinforces earlier research, including a 2023 Cochrane comprehensive review and meta-analysis, as well as a 2021 systematic review of seven randomized controlled trials.

Today, an article in Filter highlights a study from Italy showing that people who quit smoking using nicotine e‑cigarettes or heated tobacco products experienced a significant increase in VO2max, the maximum amount of oxygen the body can use during intense exercise—a key measure of cardiovascular fitness and endurance. The 12-week randomized controlled trial found “quitters showed the greatest improvement in VO2max at both week 4 and week 12.” They observed no significant differences between those who used e‑cigarettes to quit and those who used heated tobacco products.

Heated tobacco devices, which resemble e‑cigarettes, deliver nicotine by heating tobacco to around 600°F—far lower than the 1300°F combustion temperature of cigarettes. Unlike e‑cigarettes, which vaporize liquid nicotine without tobacco, these devices create an aerosol with significantly fewer harmful chemicals than cigarette smoke. They offer a less toxic way to consume tobacco and nicotine, making them a valuable tool for harm reduction.

Although heated tobacco products are popular in Europe and Japan, the Food and Drug Administration has delayed their widespread availability in the US. Most users don’t turn to these products to quit smoking but to enjoy tobacco in a safer form. Evidence from Japan shows that they reduce cigarette sales and have limited appeal to youth. In 2022, the European Union banned flavored heated tobacco products. While the US hasn’t followed suit, as of early 2023, the FDA has only permitted adults to access a few heated tobacco products, all tobacco-flavored.

Yet as lawmakers and policymakers at the state and federal levels continue exploring ways to restrict nicotine delivery systems that don’t involve combustible tobacco, the evidence continues to grow that they offer adults a safer way to consume nicotine.

Previous Post

Copper Tariffs Are the New Steel Tariffs

Next Post

Congress Should Restore the Proper Incentives for Public-Interest Litigation

Next Post
Congress Should Restore the Proper Incentives for Public-Interest Litigation

Congress Should Restore the Proper Incentives for Public-Interest Litigation

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.